Tourbillon Capital Partners as of Dec. 31, 2017
Portfolio Holdings for Tourbillon Capital Partners
Tourbillon Capital Partners holds 36 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPECTRUM BRANDS Hldgs | 20.9 | $566M | 5.0M | 112.40 | |
| Spdr S&p 500 Etf (SPY) | 14.8 | $400M | 1.5M | 266.86 | |
| Alexion Pharmaceuticals | 8.4 | $227M | 1.9M | 119.59 | |
| FleetCor Technologies | 7.0 | $188M | 979k | 192.43 | |
| Sarepta Therapeutics (SRPT) | 6.4 | $174M | 3.1M | 55.64 | |
| DISH Network | 5.5 | $149M | 3.1M | 47.75 | |
| Vantiv Inc Cl A | 4.9 | $133M | 1.8M | 73.55 | |
| Arconic | 3.6 | $97M | 3.6M | 27.25 | |
| Amicus Therapeutics (FOLD) | 2.5 | $68M | 4.7M | 14.39 | |
| Service Corporation International (SCI) | 2.5 | $67M | 1.8M | 37.32 | |
| Cognizant Technology Solutions (CTSH) | 2.5 | $66M | 931k | 71.02 | |
| Synchrony Financial (SYF) | 2.4 | $66M | 1.7M | 38.61 | |
| Discovery Communications | 1.8 | $48M | 2.2M | 22.38 | |
| Aetna | 1.7 | $45M | 250k | 180.39 | |
| Hca Holdings (HCA) | 1.6 | $44M | 500k | 87.84 | |
| Nevro (NVRO) | 1.5 | $40M | 585k | 69.04 | |
| Fgl Holdings | 1.4 | $39M | 3.9M | 10.07 | |
| Sunopta (STKL) | 1.2 | $32M | 4.2M | 7.75 | |
| Incyte Corporation (INCY) | 1.0 | $28M | 295k | 94.71 | |
| Envision Healthcare | 1.0 | $26M | 756k | 34.56 | |
| Visa (V) | 0.9 | $26M | 225k | 114.02 | |
| Merck & Co (MRK) | 0.9 | $24M | 425k | 56.27 | |
| Humana (HUM) | 0.8 | $22M | 90k | 248.07 | |
| Green Plains Partners | 0.8 | $22M | 1.2M | 18.70 | |
| Gw Pharmaceuticals Plc ads | 0.7 | $20M | 148k | 132.01 | |
| Radius Health | 0.6 | $16M | 500k | 31.77 | |
| Boston Scientific Corporation (BSX) | 0.6 | $15M | 615k | 24.79 | |
| Republic Services (RSG) | 0.5 | $14M | 200k | 67.61 | |
| Macquarie Infrastructure Company | 0.4 | $12M | 184k | 64.20 | |
| Post Holdings Inc Common (POST) | 0.4 | $9.9M | 125k | 79.23 | |
| Leidos Holdings (LDOS) | 0.2 | $5.0M | 78k | 64.57 | |
| Global Blood Therapeutics In | 0.2 | $4.9M | 126k | 39.35 | |
| Voyager Therapeutics (VYGR) | 0.1 | $3.8M | 230k | 16.60 | |
| Krystal Biotech (KRYS) | 0.1 | $2.7M | 252k | 10.52 | |
| Nightstar Therapeutics | 0.1 | $2.2M | 171k | 13.12 | |
| Newmark Group (NMRK) | 0.0 | $795k | 50k | 15.90 |
